Flagship Harbor Advisors LLC Has $834,000 Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Flagship Harbor Advisors cut its stake in Intuitive Surgical by 83.7% in Q4, selling 7,555 shares and retaining 1,472 shares valued at about $834,000.
• Company insiders engaged in notable selling last quarter — including SVP Patricia Wadors and VP Fredrik Widman — with insiders selling a total of 32,943 shares worth $17.28 million, leaving insiders with roughly 0.60% ownership.
• Analysts rate ISRG a "Moderate Buy" with a consensus price target near $607; Goldman Sachs maintained a Buy but trimmed its target to $609 while some sell‑side voices (e.g., Evercore) signal potential near‑term downside.

Flagship Harbor Advisors LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 83.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,472 shares of the medical equipment provider's stock after selling 7,555 shares during the period. Flagship Harbor Advisors LLC's holdings in Intuitive Surgical were worth $834,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Newbridge Financial Services Group Inc. increased its position in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 33 shares in the last quarter. Holos Integrated Wealth LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $25,000. Olistico Wealth LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $27,000. Finally, Caitlin John LLC acquired a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Insider Activity

In other news, SVP Patricia L. Wadors sold 220 shares of the firm's stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Fredrik Widman sold 133 shares of the firm's stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares of the company's stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is owned by company insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive’s push to embed AI into its da Vinci systems reinforces the company’s long‑term growth and margin story, supporting investor confidence in recurring procedure growth and software monetization. AI Push Article
• Positive Sentiment: Goldman Sachs kept a Buy rating on ISRG, signaling continued institutional support despite lowering its price target to $609 — the maintained Buy reduces downside risk for some investors. Goldman Sachs PT Article
• Positive Sentiment: Third‑party coverage highlights Intuitive’s strong balance sheet (no debt) and near‑monopoly position in robotic surgery — a supportive fundamental narrative for long‑term investors. Fool No‑Debt Article
• Positive Sentiment: Analysts and commentators point to an underappreciated large opportunity in anti‑obesity procedures that could widen Intuitive’s TAM and future procedure volumes. Anti‑Obesity Opportunity Article
• Neutral Sentiment: Market summaries note ISRG rose today but underperformed the market, suggesting selective buying rather than broad momentum. Zacks Market Summary
• Neutral Sentiment: Erste Group trimmed FY2027 EPS estimates very slightly (from $9.54 to $9.52) — the change is immaterial to near‑term outlook but reflects close monitoring of margins and procedure growth.
• Negative Sentiment: Evercore published a pessimistic forecast for ISRG, introducing downside bias from a well‑known sell‑side voice that can influence short‑term flows and sentiment. Evercore Forecast Article
• Negative Sentiment: Goldman’s sizable cut to its price target (from $714 to $609) signals valuation pressure — even with a Buy rating, lower targets can prompt profit‑taking or cap repositioning by funds. Goldman Sachs PT Article

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $462.28 on Thursday. The firm has a 50-day moving average of $483.27 and a 200-day moving average of $514.06. The stock has a market cap of $164.17 billion, a PE ratio of 58.59, a PEG ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analysts' expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical's revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.21 earnings per share. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Weiss Ratings reiterated a "hold (c+)" rating on shares of Intuitive Surgical in a research report on Monday, December 29th. Citigroup raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and set a $590.00 price target on the stock in a research note on Wednesday, March 11th. Royal Bank Of Canada lifted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, December 17th. HSBC lifted their price target on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a "buy" rating in a research note on Monday, January 26th. Finally, Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $655.00 to $645.00 and set an "outperform" rating on the stock in a report on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $607.00.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.